Baxter Publishes Annual Corporate Responsibility Report, Highlighting Continued Focus on Creating Lasting Impact
July 11, 2024
July 11, 2024
DEERFIELD, Illinois, July 11 (TNSres) -- Baxter International, a health care company that focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions, issued the following news release on July 10, 2024:
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2023 Corporate Responsibility Report. The annual report showcases Baxter's dedication to making a meaningful difference in global healt . . .
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2023 Corporate Responsibility Report. The annual report showcases Baxter's dedication to making a meaningful difference in global healt . . .